In vitro, Zerumbone can increase levels of PARK7, Nrf2 and HO-1, improve the viability of human neuroblastoma cells treated with 1-methyl-4-phenylpyridinium and reduce the ROS content and the number of apoptosis (Cao et al., 2018). This evidence concerns the gene NFE2L2 and neuroblastoma.